- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.56 | -20.0 | 124.0 | 0.02 | 100.0 | 0 | 0.15 | 15.38 | 87.5 | 0 | 0 | 0 | 3.57 | 150.0 | 0 | 26.79 | 44.23 | -16.29 | 0.00 | 0 | 0 | 136 | 0.0 | 4.62 |
24Q2 (19) | 0.7 | 89.19 | 775.0 | 0.01 | 0.0 | 0 | 0.13 | -18.75 | 85.71 | 0 | 0 | 0 | 1.43 | -47.14 | 0 | 18.57 | -57.05 | -78.78 | 0.00 | 0 | 0 | 136 | 0.0 | 4.62 |
24Q1 (18) | 0.37 | 94.74 | 85.0 | 0.01 | 0.0 | 0 | 0.16 | 45.45 | 45.45 | 0 | 0 | 0 | 2.70 | -48.65 | 0 | 43.24 | -25.31 | -21.38 | 0.00 | 0 | 0 | 136 | 0.0 | 4.62 |
23Q4 (17) | 0.19 | -24.0 | -84.03 | 0.01 | 0 | -50.0 | 0.11 | 37.5 | 10.0 | 0 | 0 | 0 | 5.26 | 0 | 213.16 | 57.89 | 80.92 | 588.95 | 0.00 | 0 | 0 | 136 | 4.62 | 4.62 |
23Q3 (16) | 0.25 | 212.5 | -86.26 | 0 | 0 | -100.0 | 0.08 | 14.29 | -27.27 | 0 | 0 | 0 | 0.00 | 0 | -100.0 | 32.00 | -63.43 | 429.45 | 0.00 | 0 | 0 | 130 | 0.0 | 21.5 |
23Q2 (15) | 0.08 | -60.0 | -96.06 | 0 | 0 | -100.0 | 0.07 | -36.36 | -30.0 | 0 | 0 | 0 | 0.00 | 0 | -100.0 | 87.50 | 59.09 | 1676.25 | 0.00 | 0 | 0 | 130 | 0.0 | 21.5 |
23Q1 (14) | 0.2 | -83.19 | -88.76 | 0 | -100.0 | -100.0 | 0.11 | 10.0 | 10.0 | 0 | 0 | 0 | 0.00 | -100.0 | -100.0 | 55.00 | 554.5 | 879.0 | 0.00 | 0 | 0 | 130 | 0.0 | 21.5 |
22Q4 (13) | 1.19 | -34.62 | 13.33 | 0.02 | -33.33 | -33.33 | 0.1 | -9.09 | 0.0 | 0 | 0 | 0 | 1.68 | 1.96 | -41.18 | 8.40 | 39.04 | -11.76 | 0.00 | 0 | 0 | 130 | 21.5 | 21.5 |
22Q3 (12) | 1.82 | -10.34 | 119.28 | 0.03 | -25.0 | 200.0 | 0.11 | 10.0 | 10.0 | 0 | 0 | 0 | 1.65 | -16.35 | 36.81 | 6.04 | 22.69 | -49.84 | 0.00 | 0 | 0 | 107 | 0.0 | -30.97 |
22Q2 (11) | 2.03 | 14.04 | 14.04 | 0.04 | 0.0 | 0.0 | 0.1 | 0.0 | -9.09 | 0 | 0 | 0 | 1.97 | -12.32 | -12.32 | 4.93 | -12.32 | -20.29 | 0.00 | 0 | 0 | 107 | 0.0 | -30.97 |
22Q1 (10) | 1.78 | 69.52 | -14.01 | 0.04 | 33.33 | -20.0 | 0.1 | 0.0 | -28.57 | 0 | 0 | 0 | 2.25 | -21.35 | -6.97 | 5.62 | -41.01 | -16.93 | 0.00 | 0 | 0 | 107 | 0.0 | -30.97 |
21Q4 (9) | 1.05 | 26.51 | -38.6 | 0.03 | 200.0 | -25.0 | 0.1 | 0.0 | -28.57 | 0 | 0 | 0 | 2.86 | 137.14 | 22.14 | 9.52 | -20.95 | 16.33 | 0.00 | 0 | 0 | 107 | -30.97 | -30.97 |
21Q3 (8) | 0.83 | -53.37 | -50.0 | 0.01 | -75.0 | -75.0 | 0.1 | -9.09 | -9.09 | 0 | 0 | 0 | 1.20 | -46.39 | -50.0 | 12.05 | 94.96 | 81.82 | 0.00 | 0 | 0 | 155 | 0.0 | -0.64 |
21Q2 (7) | 1.78 | -14.01 | 16.34 | 0.04 | -20.0 | 0.0 | 0.11 | -21.43 | 10.0 | 0 | 0 | 0 | 2.25 | -6.97 | -14.04 | 6.18 | -8.63 | -5.45 | 0.00 | 0 | 0 | 155 | 0.0 | -0.64 |
21Q1 (6) | 2.07 | 21.05 | 69.67 | 0.05 | 25.0 | 25.0 | 0.14 | 0.0 | 16.67 | 0 | 0 | 0 | 2.42 | 3.26 | -26.33 | 6.76 | -17.39 | -31.24 | 0.00 | 0 | 0 | 155 | 0.0 | -9.36 |
20Q4 (5) | 1.71 | 3.01 | 54.05 | 0.04 | 0.0 | 33.33 | 0.14 | 27.27 | -6.67 | 0 | 0 | 0 | 2.34 | -2.92 | -13.45 | 8.19 | 23.55 | -39.42 | 0.00 | 0 | 0 | 155 | -0.64 | -9.36 |
20Q3 (4) | 1.66 | 8.5 | 0.0 | 0.04 | 0.0 | 0.0 | 0.11 | 10.0 | 0.0 | 0 | 0 | 0.0 | 2.41 | -7.83 | 0.0 | 6.63 | 1.39 | 0.0 | 0.00 | 0 | 0.0 | 156 | 0.0 | 0.0 |
20Q2 (3) | 1.53 | 25.41 | 0.0 | 0.04 | 0.0 | 0.0 | 0.1 | -16.67 | 0.0 | 0 | 0 | 0.0 | 2.61 | -20.26 | 0.0 | 6.54 | -33.55 | 0.0 | 0.00 | 0 | 0.0 | 156 | -8.77 | 0.0 |
20Q1 (2) | 1.22 | 9.91 | 0.0 | 0.04 | 33.33 | 0.0 | 0.12 | -20.0 | 0.0 | 0 | 0 | 0.0 | 3.28 | 21.31 | 0.0 | 9.84 | -27.21 | 0.0 | 0.00 | 0 | 0.0 | 171 | 0.0 | 0.0 |
19Q4 (1) | 1.11 | 0.0 | 0.0 | 0.03 | 0.0 | 0.0 | 0.15 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 2.70 | 0.0 | 0.0 | 13.51 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 171 | 0.0 | 0.0 |
營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 0.72 | -89.44 | 0.02 | -84.62 | 0.38 | -9.52 | 0 | 0 | 2.78 | 45.73 | 52.78 | 757.01 | 0.00 | 0 | 130 | 0.0 |
2022 (9) | 6.82 | 19.02 | 0.13 | 0.0 | 0.42 | -4.55 | 0 | 0 | 1.91 | -15.98 | 6.16 | -19.8 | 0.00 | 0 | 130 | 21.5 |
2021 (8) | 5.73 | -6.53 | 0.13 | -23.53 | 0.44 | -4.35 | 0 | 0 | 2.27 | -18.19 | 7.68 | 2.33 | 0.00 | 0 | 107 | -30.97 |
2020 (7) | 6.13 | 2.68 | 0.17 | 0.0 | 0.46 | -8.0 | 0 | 0 | 2.77 | -2.61 | 7.50 | -10.4 | 0.00 | 0 | 155 | -0.64 |
2019 (6) | 5.97 | -29.01 | 0.17 | -22.73 | 0.5 | -5.66 | 0 | 0 | 2.85 | 8.85 | 8.38 | 32.9 | 0.00 | 0 | 156 | -8.77 |
2018 (5) | 8.41 | 102.16 | 0.22 | -15.38 | 0.53 | 26.19 | 0 | 0 | 2.62 | -58.15 | 6.30 | -37.58 | 0.00 | 0 | 171 | 3.01 |
2017 (4) | 4.16 | -22.68 | 0.26 | 52.94 | 0.42 | -26.32 | 0 | 0 | 6.25 | 97.79 | 10.10 | -4.71 | 0.00 | 0 | 166 | 3.11 |
2016 (3) | 5.38 | -5.78 | 0.17 | 0.0 | 0.57 | 23.91 | 0 | 0 | 3.16 | 6.13 | 10.59 | 31.51 | 0.00 | 0 | 161 | -8.52 |
2015 (2) | 5.71 | -21.24 | 0.17 | -29.17 | 0.46 | 6.98 | 0 | 0 | 2.98 | -10.06 | 8.06 | 35.83 | 0.00 | 0 | 176 | -27.27 |
2014 (1) | 7.25 | 14.17 | 0.24 | 0.0 | 0.43 | 30.3 | 0 | 0 | 3.31 | 0 | 5.93 | 0 | 0.00 | 0 | 242 | 49.38 |